Lv22
120 积分 2026-01-09 加入
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?
7天前
已完结
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?
19天前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
26天前
已完结
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
26天前
已完结
Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine
1个月前
已完结
95 Initial Validation of the Radical Prostatectomy Questionnaire (RPQ): A New Patient Reported Outcome (PRO) to Assess Sexual Function following Radical Prostatectomy (RP)
1个月前
已关闭
087 Initial Validation of the Radical Prostatectomy Questionnaire (RPQ): A New Patient Reported Outcome (PRO) to Assess Sexual Function Following Radical Prostatectomy (RP)
1个月前
已关闭
A brief male sexual function inventory for urology
1个月前
已完结
087 Initial Validation of the Radical Prostatectomy Questionnaire (RPQ): A New Patient Reported Outcome (PRO) to Assess Sexual Function Following Radical Prostatectomy (RP)
1个月前
已关闭
The Treatment Satisfaction Scale: A Multidimensional Instrument for the Assessment of Treatment Satisfaction for Erectile Dysfunction Patients and Their Partners
1个月前
已完结
皖公网安备34019202002308
